Cargando…

Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes

INTRODUCTION: At a Veterans Affairs Medical Center (VAMC), a clinical pharmacist practitioner (CPP) was added to an inpatient addiction triage team in August 2019 to provide education and recommendations regarding medications for alcohol use disorder (MAUD) and opioid use disorder (MOUD). Before the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehrhard, Kim, Colvard, Michelle, Brabson, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Psychiatric Pharmacists 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405629/
https://www.ncbi.nlm.nih.gov/pubmed/36071740
http://dx.doi.org/10.9740/mhc.2022.08.219
_version_ 1784773924650745856
author Ehrhard, Kim
Colvard, Michelle
Brabson, Jennifer
author_facet Ehrhard, Kim
Colvard, Michelle
Brabson, Jennifer
author_sort Ehrhard, Kim
collection PubMed
description INTRODUCTION: At a Veterans Affairs Medical Center (VAMC), a clinical pharmacist practitioner (CPP) was added to an inpatient addiction triage team in August 2019 to provide education and recommendations regarding medications for alcohol use disorder (MAUD) and opioid use disorder (MOUD). Before the addition of the CPP, missed opportunities for MAUD and MOUD education and prescribing prior to discharge on non-psychiatric units were observed. METHODS: This was a single-center, single-site, retrospective, observational cohort study with a primary objective to compare initiation rates of MAUD/MOUD 12 months before and after the addition of the CPP to the addiction triage team. Secondary end points included 90-day medication possession ratio, 1- and 3-month emergency department visit rates, 1- and 3-month hospital readmission rates, and opioid education and naloxone distribution interventions for eligible patients with a diagnosis of opioid use disorder. RESULTS: Both statistically and clinically significant improvements in MAUD/MOUD initiation rates were found in the CPP intervention group compared with the historical control group (26.3% vs 4%, P < .0001). Although secondary end points within this review were not found to be statistically significant, improvements were seen in the CPP intervention group compared with the historical control group related to medication possession ratio, and emergency department and hospital readmission rates. DISCUSSION: This study highlights the potential utility of a CPP to an inpatient addiction triage team to improve MAUD/MOUD prescribing rates in appropriate patients prior to discharge. Overall, the introduction of a CPP to an inpatient addiction triage team was feasible, well received by interprofessional team members, and required limited additional resources.
format Online
Article
Text
id pubmed-9405629
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Association of Psychiatric Pharmacists
record_format MEDLINE/PubMed
spelling pubmed-94056292022-09-06 Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes Ehrhard, Kim Colvard, Michelle Brabson, Jennifer Ment Health Clin Original Research INTRODUCTION: At a Veterans Affairs Medical Center (VAMC), a clinical pharmacist practitioner (CPP) was added to an inpatient addiction triage team in August 2019 to provide education and recommendations regarding medications for alcohol use disorder (MAUD) and opioid use disorder (MOUD). Before the addition of the CPP, missed opportunities for MAUD and MOUD education and prescribing prior to discharge on non-psychiatric units were observed. METHODS: This was a single-center, single-site, retrospective, observational cohort study with a primary objective to compare initiation rates of MAUD/MOUD 12 months before and after the addition of the CPP to the addiction triage team. Secondary end points included 90-day medication possession ratio, 1- and 3-month emergency department visit rates, 1- and 3-month hospital readmission rates, and opioid education and naloxone distribution interventions for eligible patients with a diagnosis of opioid use disorder. RESULTS: Both statistically and clinically significant improvements in MAUD/MOUD initiation rates were found in the CPP intervention group compared with the historical control group (26.3% vs 4%, P < .0001). Although secondary end points within this review were not found to be statistically significant, improvements were seen in the CPP intervention group compared with the historical control group related to medication possession ratio, and emergency department and hospital readmission rates. DISCUSSION: This study highlights the potential utility of a CPP to an inpatient addiction triage team to improve MAUD/MOUD prescribing rates in appropriate patients prior to discharge. Overall, the introduction of a CPP to an inpatient addiction triage team was feasible, well received by interprofessional team members, and required limited additional resources. American Association of Psychiatric Pharmacists 2022-08-23 /pmc/articles/PMC9405629/ /pubmed/36071740 http://dx.doi.org/10.9740/mhc.2022.08.219 Text en © 2022 AAPP. The Mental Health Clinician is a publication of the American Association of Psychiatric Pharmacists. https://creativecommons.org/licenses/by-nc/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Ehrhard, Kim
Colvard, Michelle
Brabson, Jennifer
Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes
title Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes
title_full Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes
title_fullStr Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes
title_full_unstemmed Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes
title_short Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes
title_sort addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405629/
https://www.ncbi.nlm.nih.gov/pubmed/36071740
http://dx.doi.org/10.9740/mhc.2022.08.219
work_keys_str_mv AT ehrhardkim additionofaclinicalpharmacistpractitionertoaninpatientaddictiontriageteamandrelatedmedicationoutcomes
AT colvardmichelle additionofaclinicalpharmacistpractitionertoaninpatientaddictiontriageteamandrelatedmedicationoutcomes
AT brabsonjennifer additionofaclinicalpharmacistpractitionertoaninpatientaddictiontriageteamandrelatedmedicationoutcomes